Now Reading: Ajay Devgn challenges FDA show-cause notice over Vimal Elaichi ad
-
01
Ajay Devgn challenges FDA show-cause notice over Vimal Elaichi ad
The Story in Brief
Bollywood actor Ajay Devgn has moved the Bombay High Court challenging a show-cause notice from the Maharashtra Food and Drugs Administration over his appearance in advertisements for ‘Vimal Elaichi’, which the FDA alleges is surrogate promotion for banned pan masala. The petition is likely to be heard by a division bench of Chief Justice Mahesh C Tripathi and Justice Advait Sethna on November 4.
Indian Opinion Analysis
Both sources report the same facts but differ in their focus. Barandbench.com leads with Ajay Devgn's legal challenge, detailing his petition's arguments and the earlier Delhi High Court ruling, while Economic Times leads with the FDA chief announcing that proceedings against the trio are complete and the matter is moving to adjudication. The barandbench.com account omits the FDA chief's statement that adjudication will proceed irrespective of Devgn's petition, whereas Economic Times includes that assertion. The coverage is uniform in reporting the core dispute: surrogate advertising for Vimal Pan Masala. The key open point is the November 4 hearing before the Bombay High Court and the FDA's planned adjudication referral by next week.
Coverage: 2 sources, 2 neutral
Sources (2): barandbench.com (neutral report), economictimes.indiatimes.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.
